If you’re struggling to lose weight, you probably feel like the odds are stacked against you. You’re not necessarily wrong. “There is so much great-tasting food, and it’s abundant and in your face all the time. To me it’s kind of a miracle that people aren’t […]
Read More
As evidence supporting the use of electroconvulsive therapy (ECT) to treat patients with depression and other psychiatric illnesses continues to grow, myths about this treatment persist. In light of these myths, patients might be reluctant to receive ECT. As clinicians, we need to educate patients about […]
Read More
If personality is the cluster of traits which form the uniform of the one either he or She. Magnified certain traits in one person can be disturbing others but the person himself/herself might not feel disturbed. Here is the sum of personality disorders cluster traits. […]
Read More
Clozapine What’s of Interest: Clozapine REMS and ANC monitoring update Brands Clozaril, Leponex, Versacloz (oral suspension), Fazaclo ODT (oral disintegrating tablet) Class Atypical antipsychotic (serotonin-dopamine antagonist; second-generation antipsychotic; also a mood stabilizer) Approved For: Treatment-resistant schizophrenia Reduction in risk of recurrent suicidal behavior in patients […]
Read More
1 AGOMELATINE THERAPEUTICS Brands • Valdoxan see index for additional brand names Generic? No Class • Neuroscience-based Nomenclature: melatonin multi-modal (Mel-MM) • Agonist at melatonergic 1 and melatonergic 2 receptors • Antagonist at 5HT2C receptors Commonly Prescribed for (bold for FDA approved) • Depression How the […]
Read More
What’s of Interest: Latuda is now approved for pediatric bipolar depression (ages 10 and older) Brands Latuda Class Atypical antipsychotic (serotonin-dopamine antagonist; second generation antipsychotic; also a mood stabilizer) Approved For: Schizophrenia (ages 13 and older) Bipolar depression (ages 10 and older, monotherapy) Bipolar depression (adults, […]
Read More
Current Psychiatry. 2018 July;17(7):4,6 By Henry A. Nasrallah, MD Recently, contemporary “culture” has capriciously confounded and confused our national community with a cringe-worthy “C” word. Unfortunately, this was followed by only transient public consternation, reflecting the coarsening of our social communication and discourse and the cant of many. But the ripple effects continue. As […]
Read More
What is Epidiolex? Epidiolex is an oral liquid-based drug made from the cannabidiol (CBD) portion of cannabis. Compared to the tetrahydrocannabinol (THC) portion, CBD is not psychoactive, so taking this drug would not result in a high for the user. CBD acts on different parts of […]
Read MoreThe US FDA has approved the first non-opioid treatment for the relief of opioid withdrawal symptoms. The medication, lofexidine hydrochloride (trade name Lucemyra), is an oral, selective alpha-2 adrenergic receptor agonist that reduces the release of norepinephrine, which may lead to relief of autonomic […]
Read MoreCurrent Psychiatry. 2017 October;16(10):4,6-7 Author(s): Henry A. Nasrallah, MD Author and Disclosure Information Imagine the rich landscape of psychopathology as an Amazon jungle. The DSM diagnostic schema describes the individual trees but overlooks the fascinating patterns within the forest. It does not adequately inform psychiatric practitioners about […]
Read More
